Vyvanse Withdrawal: Symptoms, Timeline, and What to Expect

Vyvanse withdrawal is the stimulant crash that follows stopping Vyvanse, the brand name for lisdexamfetamine, a prescription stimulant approved to treat attention-deficit hyperactivity disorder and, in adults, moderate to severe binge eating disorder. Vyvanse is a Schedule II controlled substance, the same category as other amphetamine medications, which reflects both its medical value and its potential for misuse and dependence. When a person stops taking Vyvanse after heavy or long-term use, the body and brain need time to readjust, and that readjustment period is what people commonly call withdrawal or the stimulant crash.

This page is educational. It describes what withdrawal from Vyvanse can look like and offers a general timeline so the experience feels less mysterious. It is not a substitute for medical advice, and it is not a guide for stopping a prescribed medication on one's own. Decisions about starting, changing, or stopping Vyvanse belong with the prescribing clinician, who can weigh a person's history and taper the dose safely when that is the right step.

Why Stopping Vyvanse Causes a Crash

Vyvanse works by increasing the activity of dopamine and norepinephrine, brain chemicals tied to focus, motivation, energy, and mood. Lisdexamfetamine is a prodrug, meaning it is inactive until the body converts it into dextroamphetamine, which produces a smoother and longer-lasting effect than some other stimulants. With regular use, especially at higher doses or over long periods, the brain adapts to the steady presence of the medication and adjusts its own chemistry to compensate.

When the medication is removed, that adaptation is suddenly out of balance. Dopamine and norepinephrine activity drops below the level the brain has come to expect, and the result is often the opposite of the medication's effects: fatigue instead of energy, low mood instead of focus, and a strong pull toward feeling normal again. This rebound is the crash. It is generally not medically dangerous in the way that alcohol or benzodiazepine withdrawal can be, but it can be genuinely difficult, and for some people it carries real emotional risk that deserves attention.

Common Symptoms of Vyvanse Withdrawal

Because Vyvanse is a stimulant, its withdrawal tends to be marked by a slowing down of body and mind rather than the agitation seen with some other substances. Symptoms vary from person to person and depend on the dose, how long the medication was used, and whether it was taken as prescribed or misused. The most commonly reported effects include the following.

• Fatigue and low energy, sometimes with a strong urge to sleep for long stretches.
• Depressed mood, irritability, or a flat, joyless feeling that can last several days.
• Increased appetite, as the appetite-suppressing effect of the stimulant fades.
• Sleep changes, including vivid dreams, oversleeping early on, or difficulty settling into a normal rhythm.
• Difficulty concentrating, mental fog, and slowed thinking.
• Cravings for the medication or for the energy and focus it provided.
• Anxiety or restlessness in some people, even amid the overall fatigue.

A General Timeline for the Vyvanse Crash

There is no single timeline that fits everyone, because withdrawal depends on the dose, the length of use, individual biology, and whether the stop was gradual or abrupt. The pattern below is a general guide drawn from how stimulant withdrawal commonly unfolds, not a prediction for any one person. Lisdexamfetamine has a relatively long duration compared with some stimulants, so the crash may begin somewhat later than it would with a short-acting drug.

Why Tapering Should Be Clinician-Directed

The safest way to come off Vyvanse is under the guidance of the clinician who prescribed it. A prescriber can decide whether to lower the dose gradually, a process called tapering, which gives the brain more time to readjust and often softens the crash. A prescriber can also check for an underlying condition that the medication was treating, such as ADHD, and make sure it does not go unmanaged when the stimulant stops.

Stopping abruptly is not usually physically dangerous, but it tends to make the crash feel sharper, and it can leave the original condition untreated at the same time that mood and energy are dropping. That combination is hard on a person. Working with a clinician also means someone is watching for the more serious risks, especially a deep drop in mood, and can adjust the plan quickly if those appear.

When Vyvanse Use Signals a Larger Problem

For most people, a Vyvanse crash after a prescribed course is a temporary adjustment. But repeated cycles of running out early, taking more than prescribed, using someone else's medication, or crushing and snorting the drug to intensify its effect point toward a stimulant use disorder rather than ordinary dependence. So does continuing to use despite clear harm to health, relationships, work, or school.

There is no medication approved to reverse a stimulant use disorder the way there is for opioids, so treatment centers on evidence-based behavioral therapies, structure, and support. This is also a moment where co-occurring mental health conditions matter. Depression and anxiety often travel alongside stimulant use, and the low mood of withdrawal can unmask or deepen them. Addressing both the substance use and the mental health picture together tends to work far better than treating either alone.

What Influences How Hard the Crash Feels

No two people experience a Vyvanse crash in exactly the same way, and several factors shape how intense and how long it feels. The dose matters, because a higher dose creates a larger gap for the brain to close once the medication is gone. So does the length of use, since months or years of steady exposure allow deeper adaptation than a few weeks. How the medication was taken also plays a part: a person who took Vyvanse exactly as prescribed usually has a gentler experience than someone who escalated the dose, used it more often than directed, or altered it to intensify the effect.

• Dose and how long the medication was used, which together shape how much the brain has adapted.
• Whether the stimulant was taken as prescribed or misused, since misuse tends to sharpen withdrawal.
• Individual biology, including metabolism, age, and overall health.
• Sleep quality and nutrition in the weeks around stopping, which influence energy and mood.
• Co-occurring mental health conditions such as depression or anxiety, which the crash can unmask or deepen.
• Whether the stop was abrupt or a gradual, clinician-directed taper.

What Recovery Looks Like After the Peak

For most people the sharpest part of a stimulant crash passes within the first week or two, but recovery is rarely a straight line. Some describe a lingering flatness, a sense that ordinary activities feel less rewarding than they once did. This is sometimes called anhedonia, and it reflects the time the brain's dopamine system needs to return to its usual rhythm. It generally eases as the weeks pass, though its persistence can be discouraging for a person who expected to feel fully normal within days.

Sleep and appetite tend to settle before mood and motivation do. A person may find that energy returns first, then concentration, with emotional steadiness arriving last. Cravings, when they appear, often come in waves rather than as a constant pull, and they tend to be triggered by stress, fatigue, or reminders of past use. Knowing that this uneven pattern is normal can make the recovery period feel less alarming, and it underscores why support during these weeks is worthwhile even after the worst of the crash has passed.

The Role of an Underlying Condition

Vyvanse is prescribed for a reason, most often ADHD or, in adults, moderate to severe binge eating disorder. When the medication stops, the symptoms it was managing can return, and that return can be mistaken for withdrawal when it is actually the underlying condition reasserting itself. Difficulty focusing, restlessness, or disordered eating patterns may resurface, and separating what is withdrawal from what is the original condition is one of the reasons medical guidance matters so much.

A prescriber can decide whether a different, non-stimulant approach is appropriate, whether behavioral strategies can help, or whether the medication should be resumed at an adjusted dose. Leaving an underlying condition unmanaged while also weathering a crash places a heavy load on a person, and it can make the pull back toward the stimulant much stronger. Treating the whole situation, rather than only the withdrawal, gives a person a steadier footing.

Why Going Through It With Support Helps

Because a stimulant crash is rarely physically dangerous, people sometimes assume it should be handled alone and quietly. Yet the emotional side of withdrawal, the low mood, irritability, and cravings, is often what makes stopping hard to sustain, and it is exactly the part that support helps with most. Having someone watch for a deepening depression is a genuine safeguard, since the drop in mood can occasionally become severe enough to need urgent care.

Structure also helps. Regular routines around sleep, food, and gentle activity give the recovering brain a stable environment, and having people to talk to reduces the isolation that can make cravings louder. Evidence-based behavioral therapies teach practical ways to recognize triggers, manage the urge to use, and rebuild motivation while the brain's own chemistry recovers. None of this replaces a prescriber's medical guidance, but together they can be the difference between weathering a crash alone and moving through it with a plan.

How Ascend Can Help

Ascend Recovery Center in Albuquerque treats stimulant use, including prescription stimulants such as Vyvanse, within an individualized plan of care. Because no medication reverses a stimulant use disorder, the focus is on evidence-based behavioral therapies such as cognitive behavioral therapy, dialectical behavior therapy, and EMDR, alongside group, family, and wellness support that helps a person manage cravings and rebuild steady routines.

Ascend also treats co-occurring mental health conditions, and it can care for a mental health condition as the primary focus rather than only as part of a dual diagnosis. That matters for stimulant withdrawal, where low mood and anxiety are common. With a full continuum of care in one Albuquerque location and Joint Commission accreditation, a person can be assessed, stabilized, and supported through the crash and beyond without leaving the Ascend system.